Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - September 2026, Online, from 10 September 2026, 15:00 (CEST) to 10 September 2026, 16:00 (CEST)
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 2026, Online, from 8 October 2026, 15:00 (CEST) to 8 October 2026, 16:00 (CEST)
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - November 2026, Online, from 12 November 2026, 15:00 (CET) to 12 November 2026, 16:00 (CET)
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - December 2026, Online, from 10 December 2026, 15:00 (CET) to 10 December 2026, 16:00 (CET)
Human papillomavirus (HPV)
Applying for orphan designation
Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Date of authorisation: 02/06/2025, Revision: 3, Status: Authorised
Procedural advice for orphan medicinal product designation: Guidance for sponsors
Regulatory Procedure Management in IRIS roadmap
Chapter 3.II: XEVPRM detailed user guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA